Cysteamine for Treatment, Mitigation and Prevention of SARS-CoV-2 Infections
Summary
USPTO published patent application US20260097007A1 for cysteamine and derivatives for treating COVID-19 and related viral infections. Inventors are Jess Thoene and Robert Gavin. The application (No. 19415604) was filed December 10, 2025, and published April 9, 2026.
What changed
USPTO published patent application US20260097007A1 covering methods for treating, mitigating, and preventing coronavirus infections (including SARS-CoV-2 and COVID-19) using cysteamine or derivatives thereof. The application includes therapeutic method claims and pharmaceutical composition claims across multiple CPC classifications.
Pharmaceutical companies and researchers developing antiviral therapeutics should monitor this application as it may affect freedom-to-operate considerations for cysteamine-based treatments. Patent applicants and investors in COVID-19 therapeutics may find this application relevant for competitive intelligence purposes.
What to do next
- Monitor for updates
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CYSTEAMINE FOR THE TREATMENT, MITIGATION AND PREVENTION OF CORONAVIRAL, E.G., SARS-CoV-2, INFECTIONS
Application US20260097007A1 Kind: A1 Apr 09, 2026
Inventors
Jess Thoene, Robert Gavin
Abstract
Provided herein are methods for the treatment, mitigation, and prevention of viral infections (e.g., coronavirus infections (e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etc.), etc.) and diseases (e.g., Coronavirus disease 2019 (COVID-19)) associated therewith by the administration of cysteamine or derivatives thereof to a subject.
CPC Classifications
A61K 31/145 A61K 9/0043 A61K 9/0053 A61K 31/4045 A61K 31/427 A61K 31/4706 A61K 31/4965 A61K 31/513 A61K 31/661 A61K 31/675 A61P 31/14
Filing Date
2025-12-10
Application No.
19415604
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.